Redefining CVD Risk: Cardiovascular-Kidney-Metabolic (CKM) Syndrome
Citing the strong overlap between heart disease, kidney disease, type 2 diabetes, and obesity, the American Heart Association (AHA) has for the first time formally defined what they are calling cardiovascular-kidney-metabolic (CKM) syndrome.
ACP Revises Standard on Cardiorespiratory Death Determination
The American College of Physicians (ACP) has issued a new position paper on determination of death that includes a clarification to the 1981 Uniform Determination of Death Act (UDDA), but otherwise reaffirms the current standards.
New ADA/EASD Guidance on Diabetes: Assess CV Status First
The treatment approach to type 2 diabetes should begin with an assessment of cardiovascular disease (CVD) status, other comorbidities, and patient preferences, according to a draft of the upcoming 2018 joint consensus statement from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD).
The final version of the 2018 update to the current 2015 ADA/EASDManagement of Hyperglycemia in Type 2 Diabetes statement (Diabetes Care.2015;38:140-149) will be presented on October 5, 2018 at the EASD annual meeting in Berlin and will be published in Diabetes Care and Diabetologia.
Expert opinion. Double antiplatelet therapy after ACS: "de-escalation"
In medical practice, cases in which patients with acute coronary syndrome (ACS) and received a combination of acetylsalicylic acid (ASA) with prasugrel or ticagrelor are often used, a combination of ASA with clopidogrel is started. This transition from more active platelet-derived P2Y12 blockers to less active clopidogrel has been termed "de-escalation."
The possibility of "de-escalation" is considered in documents prepared by various expert groups. Among them, an updated version of the recommendations of the European Society of Cardiology and the European Association of Cardio Thoracic Surgeons for double antiplatelet therapy for coronary heart disease, where a similar transition is proposed to be discussed with side effects or intolerance of prasugrel / ticagrelor. There is also an agreement of experts from Europe and the USA, in which practical approaches to the replacement of the P2Y12 blocker of the platelet receptor are analyzed in detail. However, it should be borne in mind that these proposals are basically based on common sense and representations of the pharmacological properties of various P2Y12 receptor blockers of the platelet, while the evidence base for "de-escalation" is small.
SUMMARY & CONCLUSIONS - 71ST WORLD HEALTH ASSEMBLY
Global resolution on Rheumatic Fever and Rheumatic Heart Disease adopted at the WHA
Following years of campaigning and advocacy from WHF, our members and the global RHD community, we are delighted to announce that on Friday 25 May, Member States of the World Health Organization unanimously adopted a Global Resolution on Rheumatic Fever and Rheumatic Heart Disease at the World Health Assembly in Geneva, Switzerland.
Bread Might Be The Saltiest Part Of Your Diet, According To A New Study
When you think of salty foods, bread might not come to mind. But a new study shows that it may be a bigger contributor to sodium in your diet than you think.
Even though it doesn"t taste that salty, bread might be delivering more sodium than you think — but it all depends on which kind you eat and how much, according to a new study.
Researchers analyzed 2,000 different breads (including white, wholemeal, mixed grain, and flatbreads) sold in 32 countries around the world and found some shockingly high numbers and wide variation in the salt and sodium levels in breads. The study was conducted by the World Action on Salt & Health (WASH) at the Wolfson Institute of Preventive Medicine of Queen Mary University of London.
The Anti-statin Lobby Strikes Again: Time to Set the Record Straight
The joint Franco-German non-commercial television network ARTE recently broadcast a television programme entitled "The Big Bluff" about the link between cholesterol, cardiovascular disease, and the use of statins. The programme propounded the theory that there is absolutely no relation between blood cholesterol levels and cardiovascular disease, and asserted that cholesterol has become the "ideal villain" in cardiovascular disease through a series of "scientific approximations". In addition, the programme encouraged physicians and patients to interrupt lipid-lowering treatments and statins, in particular, to avoid any blood lipid assessment and last but not least, suggested that the recommendations issued by professional societies such as the European Society of Cardiology (ESC) are inappropriate and influenced by conflicts of interest.
Coffee Consumption and Coronary Artery Calcium Score: Cross‐Sectional Results of ELSA‐Brasil (Brazilian Longitudinal Study of Adult Health)
Coffee Consumption and Coronary Artery Calcium Score: Cross‐Sectional Results of ELSA‐Brasil (Brazilian Longitudinal Study of Adult Health)
Abstract
Background Available evidence for the relationship between coffee intake and subclinical atherosclerosis is limited and inconsistent. This study aimed to evaluate the association between coffee consumption and coronary artery calcium (CAC) in ELSA‐Brasil (Brazilian Longitudinal Study of Adult Health).
CONFERENCE NEWS
CONFERENCE NEWS
https://www.medscape.com/viewcollection/
MOMENTUM 3: HeartMate 3 Improves Stroke-Free Survival at 2 Years
TRIUMPH: Triple Low-Dose Combo Pill a Success in Hypertension
Barbershop-Based Healthcare Cuts Hypertension in Blacks
Music Boosts Exercise Capacity During Cardiac Stress Test